cancer patient Downloads
-
Immunoscore for Colon Cancer Patients - Brochure
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an ...
By Veracyte
-
Abologix - Model JAM-C - Junction Adhesion Molecule C Antibodies for Cancer Patients - Brochure
Junction Adhesion Molecule C (JAM-C) has been studied at the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the Université de Genève for over 10+ years (36 peer reviewed publications). There is in addition 60+ publications from other laboratories. JAM-C is expressed by certain lymphocytes and prominently localises to tight junctions of endotelial cells. In many ...
By Abologix
-
Abologix - Model Olfml3 - Olfactomedin-like protein 3 Antibodies for Cancer Patients - Brochure
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific monoclonal antibodies is therefore a logical scientific approach in order to develop new generation inhibitors of angiogenesis. Abologix has produced several recombinant ...
By Abologix
-
InSilicoONCO - Model CTx NeutroSim - Chemotherapy-induced Neutropenia Simulator Datasheet
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
-
InSilicoONCO - PCa GnRH Agonists Simulator Datasheet
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
-
Elekta Unity - Model MR/RT - Magnetic Resonance Radiation Therapy - Brochure
It is our goal to help you deliver the best possible radiotherapy, for every patient, every time. Designed in collaboration with industry-leading experts and world-renowned cancer research institutions, Elekta Unity—our breakthrough MR-Linac technology— positions you at the forefront of patient-centric cancer ...
-
LifeSign - Model Status BTA - Rapid Test For the Qualitative Detection - Brochure
A Rapid Test For the Qualitative Detection of Bladder Tumor Associated Antigen in Human Urine CLIA Waived. Indicated for the use as an aid in the monitoring of bladder cancer patients in conjunction with cystoscopy. Simple procedure. Accurate test results with superior sensitivity and specificity. ...
-
OncoSELECT Brochure
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer ...
By OncoDNA S.A.
-
Immunoscore - Immune-Oncology IVD Family Assays - Brochure
Use our immune-oncology IVD solutions IMMUNOSCORE in Localized Colon Cancer and IMMUNOSCORE IC in Non-Small Cell Lung Cancer to improve patient care management with immune contexture ...
By Veracyte
-
Mobetron - Intraoperative Radiation Therapy (IORT) System - Brochure
Our flagship product—the Intraop® Mobetron®—is used by the leading cancer physicians in the best hospitals, clinics and academic centers in the world. The Mobetron is the first mobile, self-shielded electron-beam linear accelerator (LINAC) machine designed to deliver Intraoperative Radiation Therapy (IORT) to cancer patients during surgery. This innovation brings safe, ...
-
Tempus xG - Brochure
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
By Tempus
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you